US

Showing 15 posts of 324 posts found.

Avastin gets US approval in kidney cancer

August 4, 2009
Research and Development, Sales and Marketing Roche, US, avastin

Roche's rising star Avastin has won US approval to treat the most common type of kidney cancer, the latest in …

The Trillion Dollar Project: US healthcare reform begins

July 17, 2009
Sales and Marketing Obama, US, healthcare, reform

The battle to determine how the US healthcare system will be reformed is heating up, with dozens of interest groups …

Effient approved in US

July 17, 2009
Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly

Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …

US approval boosts Plavix competitor

July 14, 2009
Research and Development, Sales and Marketing Effient, FDA, US, lilly

US regulator the FDA has approved Lilly and Daiichi Sankyo's Effient, a rival treatment to the world's best-selling blood-thinning drug …

Writing on the wall for ‘pay to delay’ generics deals

July 9, 2009
Research and Development, Sales and Marketing FDA, US, generics

Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …

Genzyme’s woes are a boost for Shire and Protalix

July 9, 2009
Research and Development, Sales and Marketing FDA, Genzyme, US

The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …

Depression warnings for Chantix and Zyban

July 7, 2009
Research and Development, Sales and Marketing Chantix, FDA, US, drug safety

Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …

Dendreon sets aside $50m for Provenge facility

June 24, 2009
Manufacturing and Production Dendreon, US

US biotechnology company Dendreon revealed its confidence in lead drug Provenge for prostate cancer with the announcement it will invest …

Pharma agrees cost-saving deal with US government

June 24, 2009
Sales and Marketing Medicare, US, US healthcare, healthcare

Drug makers have agreed with the US government to spend $80 billion over the next ten years in a bid …

Battle ahead for US industry over biologics patents

June 12, 2009
Research and Development, Sales and Marketing PhRMA, US, generics, industry, reform

Moves to make it easier for biosimilars to be approved in the US are gaining momentum.The pharma industry has conceded …

The pharmaceutical industry faces unprecedented barriers to evolution

June 10, 2009
Research and Development US, healthcare

Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused …

FDA to improve transparency

June 3, 2009
Research and Development FDA, US

The US medicines regulator is to boost the transparency around its decision-making, in connection with President Obama's aim to make …

US health industry outlines cost saving plans

June 3, 2009
Sales and Marketing US, US healthcare, healthcare, industry

The US healthcare industry has said how it contribute to President Obama’s drive to cut healthcare costs, and help save …

Companies poised for swine flu vaccine drive

May 29, 2009
Research and Development, Sales and Marketing US, h1n1, vaccines

Pharmaceutical manufacturers now have access to the swine flu seed virus that can be used to start full-blown production of …

Ranbaxy woes continue with antibiotic recall

May 6, 2009
Sales and Marketing Ranbaxy, US

Indian drugmaker Ranbaxy Laboratories has recalled an antibiotic on sale in the US, suggesting that it still has some way …

The Gateway to Local Adoption Series

Latest content